ELI LILLY AND COMPANY LTD - GB 

Ranking results:

Past rankings:

Ranking timeline:

Project Participation Performance(2010-01-01 - 2024-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 6
As coordinator: 0
As participant: 6
Sole participant: 0
Coordinator / Participant Ratio: 0*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2020 0 54.106.742 0 6

Networking:

Partners:

Institution:Projects [No]:
NOVARTIS PHARMA5
KATHOLIEKE UNIVERSITEIT LEUVEN4
PFIZER LIMITED4
SANOFIAVENTIS4
ASTRAZENECA3
F HOFFMANNLA ROCHE3
FORUM DES PATIENTS EUROPEENS3
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT3
JDRF INTERNATIONAL3
STICHTING RADBOUD UNIVERSITEIT3
THE UNIVERSITY OF EXETER3
BAYER2
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
GOETEBORGS UNIVERSITET2
KING'S COLLEGE LONDON2
LUND UNIVERSITY2
MEDTRONIC INTERNATIONAL TRADING SARL2
NOVO NORDISK2
STICHTING RADBOUD UNIVERSITAIR MEDISCH CENTRUM2
TEAM IT RESEARCH SL2
THE EUROPEAN INSTITUTE FOR INNOVATION THROUGH HEALTH DATA2
UNIVERSITA CATTOLICA DEL SACRO CUORE2
UNIVERSITA VITASALUTE SAN RAFFAELE2
UNIVERSITAET ULM2
UNIVERSITY COLLEGE DUBLIN2
UNIVERSITY OF CAMBRIDGE2
UNIVERSITY OF COPENHAGEN2
UNIVERSITY OF HELSINKI2
AARHUS KOMMUNEHOSPITAL AARHUS UNIVERSITY HOSPITAL1
ABBVIE INC1
ACADEMIC MEDICAL CENTRE AMSTERDAM1
AGENCIA ESPANOLA DE MEDICAMENTOS Y PRODUCTOS SANITARIOS1
AGENTSCHAP COLLEGE TER BEOORDELING VAN GENEESMIDDELEN1
AKERSHUS UNIVERSITETSSYKEHUS HF1
ATTUROS LIMITED1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
BETH ISRAEL DEACONESS MEDICAL CENTER INC NON PROFIT CORPORATION1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
CENTRE HOSPITALIER DE LUXEMBOURG1
CENTRE HOSPITALIER REGIONAL ET UNIVERSITAIRE DE LILLE1
CENTRE HOSPITALIER REGIONAL UNIVERSITAIRE NANCY1
CENTRE HOSPITALIER UNIVERSITAIRE VAUDOIS1
CHARITE UNIVERSITAETSMEDIZIN BERLIN1
CHRISTIAN ALBRECHTS UNIVERSITAET ZU KIEL1
CONSIGLIO NAZIONALE DELLE RICERCHE1
DATAPHARM LIMITED1
DATAWIZARD1
DRESDEN UNIVERSITY OF TECHNOLOGY1
ECHALLIANCE COMPANY LIMITED BY GUARANTEE1
ECOLOGIC INSTITUT GEMEINNUETZIGE1
ECT OEKOTOXIKOLOGIE1
EIDGENOESSISCHE ANSTALT FUER WASSERVERSORGUNG ABWASSERREINIGUNG UND GEWAESSERSCHUTZ1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
EURICE EUROPEAN RESEARCH AND PROJECT OFFICE1
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING1
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
FRISQ HOLDING AB1
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE GIRONA DOCTOR JOSEP TRUETA1
FUNDACIO INSTITUT UNIVERSITARI PERA LA RECERCA A L'ATENCIO PRIMARIA DE SALUT JORDI GOL I GURINA1
FUNDACIO PRIVADA INSTITUT D?INVESTIGACIO ONCOLOGICA DE VALLHEBRON1
GEORGE WASHINGTON UNIVERSITY CORPORATION1
GRUNENTHAL1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
GUARDTIME OU1
HANNOVERSCHE KINDERHEILANSTALT1
HIMSS EUROPE1
HL7 INTERNATIONAL FONDATION1
HUMAN CELL DESIGN1
HUMANITAS MIRASOLE1
HUMANITAS UNIVERSITY1
IMCYSE1
INFORMATION TECHNOLOGY FOR TRANSLATIONAL MEDICINE1
INSTITUT CATALA DE LA SALUT1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
ISTITUTO SUPERIORE DI SANITA1
JOANNEUM RESEARCH FORSCHUNGSGESELLSCHAFT MBH1
KAROLINSKA INSTITUTE1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LEUPHANA UNIVERSITAT LUNEBURG1
LIPOTYPE1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
MACCABI SHEIRUTEI BRIUT FOUNDATION1
MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH1
MDSOL EUROPE1
MEDIZINISCHE UNIVERSITAET WIEN1
MEDIZINISCHE UNIVERSITAT GRAZ1
MERCK SHARP & DOHME CORP1
METABOLON1
MINDVIEW SYMVOULOI EPIXEIRISEON KAIEREVNAS ETAIREIA PERIORISMENIS EFTHYNIS1
MYLAN IRE HEALTHCARE LIMITED1
NORSK E HELSE AS1
OBESITAS NEDERLAND BV1
OBESITY ACTION COALITION INC1
OPEN EVIDENCE1
OSLO UNIVERSITETSSYKEHUS HF1
OSPEDALE PEDIATRICO BAMBINO GESU1
OULUN YLIOPISTO1

Constancy:

Total number of partners: 191
Partner loyalty:
Frequent Partner: (> 2 projects): 38
Rare Partner: 153
Frequent / Rare Partner Ratio: 0.25

Project overview: